List of Tables
Table 1. Cell-based Flu Vaccine Market Trends
Table 2. Cell-based Flu Vaccine Market Drivers & Opportunity
Table 3. Cell-based Flu Vaccine Market Challenges
Table 4. Cell-based Flu Vaccine Market Restraints
Table 5. Global Cell-based Flu Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cell-based Flu Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Cell-based Flu Vaccine Sales Volume by Company (2019-2024) & (M Doses)
Table 8. Global Cell-based Flu Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cell-based Flu Vaccine Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Cell-based Flu Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cell-based Flu Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cell-based Flu Vaccine
Table 13. Global Cell-based Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-based Flu Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cell-based Flu Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cell-based Flu Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cell-based Flu Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cell-based Flu Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cell-based Flu Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cell-based Flu Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Doses)
Table 22. Global Cell-based Flu Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 23. Global Cell-based Flu Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 24. Global Cell-based Flu Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cell-based Flu Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cell-based Flu Vaccine Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Cell-based Flu Vaccine Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Cell-based Flu Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cell-based Flu Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cell-based Flu Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cell-based Flu Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cell-based Flu Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cell-based Flu Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Doses)
Table 34. Global Cell-based Flu Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 35. Global Cell-based Flu Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 36. Global Cell-based Flu Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cell-based Flu Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cell-based Flu Vaccine Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Cell-based Flu Vaccine Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Cell-based Flu Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cell-based Flu Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cell-based Flu Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cell-based Flu Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Cell-based Flu Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Cell-based Flu Vaccine Sales Volume by Region (M Doses): 2019 VS 2023 VS 2030
Table 46. Global Cell-based Flu Vaccine Sales Volume by Region (2019-2024) & (M Doses)
Table 47. Global Cell-based Flu Vaccine Sales Volume by Region (2025-2030) & (M Doses)
Table 48. Global Cell-based Flu Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cell-based Flu Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cell-based Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Cell-based Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Cell-based Flu Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cell-based Flu Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cell-based Flu Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cell-based Flu Vaccine Sales Volume, (2019-2024) & (M Doses)
Table 56. Key Countries/Regions Cell-based Flu Vaccine Sales Volume, (2025-2030) & (M Doses)
Table 57. GlaxoSmithKline Company Information
Table 58. GlaxoSmithKline Introduction and Business Overview
Table 59. GlaxoSmithKline Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. GlaxoSmithKline Cell-based Flu Vaccine Product Offerings
Table 61. GlaxoSmithKline Recent Development
Table 62. Sanofi Company Information
Table 63. Sanofi Introduction and Business Overview
Table 64. Sanofi Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. Sanofi Cell-based Flu Vaccine Product Offerings
Table 66. Sanofi Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Pfizer Cell-based Flu Vaccine Product Offerings
Table 71. Pfizer Recent Development
Table 72. MedImmune, LLC Company Information
Table 73. MedImmune, LLC Introduction and Business Overview
Table 74. MedImmune, LLC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. MedImmune, LLC Cell-based Flu Vaccine Product Offerings
Table 76. MedImmune, LLC Recent Development
Table 77. Intravacc Company Information
Table 78. Intravacc Introduction and Business Overview
Table 79. Intravacc Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Intravacc Cell-based Flu Vaccine Product Offerings
Table 81. Intravacc Recent Development
Table 82. CSL Limited Company Information
Table 83. CSL Limited Introduction and Business Overview
Table 84. CSL Limited Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. CSL Limited Cell-based Flu Vaccine Product Offerings
Table 86. CSL Limited Recent Development
Table 87. E. Merck KG Company Information
Table 88. E. Merck KG Introduction and Business Overview
Table 89. E. Merck KG Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. E. Merck KG Cell-based Flu Vaccine Product Offerings
Table 91. E. Merck KG Recent Development
Table 92. Novartis Company Information
Table 93. Novartis Introduction and Business Overview
Table 94. Novartis Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Novartis Cell-based Flu Vaccine Product Offerings
Table 96. Novartis Recent Development
Table 97. Danaher Corporation Company Information
Table 98. Danaher Corporation Introduction and Business Overview
Table 99. Danaher Corporation Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Danaher Corporation Cell-based Flu Vaccine Product Offerings
Table 101. Danaher Corporation Recent Development
Table 102. SINOVAC Company Information
Table 103. SINOVAC Introduction and Business Overview
Table 104. SINOVAC Cell-based Flu Vaccine Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. SINOVAC Cell-based Flu Vaccine Product Offerings
Table 106. SINOVAC Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Cell-based Flu Vaccine Downstream Customers
Table 110. Cell-based Flu Vaccine Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell-based Flu Vaccine Product Picture
Figure 2. Global Cell-based Flu Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cell-based Flu Vaccine Sales Volume (2019-2030) & (M Doses)
Figure 5. Global Cell-based Flu Vaccine Sales Price (2019-2030) & (US$/Dose)
Figure 6. Cell-based Flu Vaccine Report Years Considered
Figure 7. Global Cell-based Flu Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cell-based Flu Vaccine Players Sales Volume Ranking (2023) & (M Doses)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cell-based Flu Vaccine Revenue in 2023
Figure 10. Cell-based Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Trivalent Influenza Vaccine Picture
Figure 12. Quadrivalent Influenza Vaccine Picture
Figure 13. Global Cell-based Flu Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cell-based Flu Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Cell-based Flu Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 16. Global Cell-based Flu Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Cell-based Flu Vaccine Price by Type (2019-2030) & (US$/Dose)
Figure 18. Product Picture of Aldults
Figure 19. Product Picture of Children
Figure 20. Global Cell-based Flu Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Cell-based Flu Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Cell-based Flu Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 23. Global Cell-based Flu Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Cell-based Flu Vaccine Price by Application (2019-2030) & (US$/Dose)
Figure 25. North America Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Cell-based Flu Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Cell-based Flu Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Cell-based Flu Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Cell-based Flu Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Cell-based Flu Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Cell-based Flu Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Cell-based Flu Vaccine Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Cell-based Flu Vaccine Sales Volume (%), (2019-2030)
Figure 37. United States Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. China Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. China Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 55. India Cell-based Flu Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Cell-based Flu Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 57. India Cell-based Flu Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 58. Cell-based Flu Vaccine Industrial Chain
Figure 59. Cell-based Flu Vaccine Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed